{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:00:01Z","timestamp":1794916801348,"version":"4.9.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by complex and various clinical manifestations. The study aimed to analyze clinical features and cerebral magnetic resonance imaging (MRI) changes of hyperintense white matter (WM) lesions in SLE patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was a retrospective study based on a consecutive cohort of 1191 SLE patients; 273 patients for whom cerebral MRI data were available were enrolled to assess hyperintense WM lesions associated with SLE. Patients were assigned to two groups, i.e., with or without hyperintense WM lesions. The MRI assessment showed that the hyperintense WM lesions could be classified into three categories: type A, periventricular hyperintense WM lesions; type B, subcortical hyperintense WM lesions; and type C, multiple discrete hyperintense WM lesions. The clinical and MRI characteristics were analyzed. Factors related to hyperintense WM lesions were identified by multivariate logistic regression analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among the 273 SLE patients with available cerebral MRI scans, 35.9% (98\/273) had hyperintense WM lesions associated with SLE. The proportions of types A, B, and C were 54.1% (53\/98), 11.2% (11\/98), and 92.9% (91\/98), respectively. Fifty-one percents of the patients showed an overlap of two or three types. Type C was the most common subgroup to be combined with other types. Compared with those without hyperintense WM lesions, the patients with hyperintense WM lesions were associated with neuropsychiatric SLE (NPSLE), lupus nephritis (LN), hypertension, and hyperuricemia (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.002, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.018, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.045, and <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.036, respectively). Significantly higher rates of polyserous effusions and cardiac involvement were found in the patients with hyperintense WM lesions (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.029 and <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.027, respectively), and these patients were more likely to present with disease damage (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.001). In addition, the patients with hyperintense WM lesions exhibited a higher frequency of proteinuria (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.009) and higher levels of CD8<jats:sup>\n                                    +\n                                 <\/jats:sup> T cells (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.005). In the multivariate logistic analysis, hyperuricemia and higher CD8<jats:bold>+<\/jats:bold> T cells percentages were significantly correlated with hyperintense WM lesions in SLE patients (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.019; OR 2.129, 95% confidence interval [CI] 1.313\u20134.006 and <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.001; OR 1.056, 95% CI 1.023\u20131.098, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Hyperintense WM lesions are common in SLE patients and significantly associated with systemic involvement, including NPSLE, LN, polyserous effusions, cardiac involvement, and disease damage. Hyperuricemia and a higher number of CD8<jats:bold>+<\/jats:bold> T cells were independent factors associated with hyperintense WM lesions in SLE.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002074","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T13:04:59Z","timestamp":1646831099000},"page":"962-970","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Features of hyperintense white matter lesions and clinical relevance in systemic lupus erythematosus"],"prefix":"10.1097","volume":"135","author":[{"given":"Qian","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China"},{"name":"Department of Rheumatology and Immunology, Peking University International Hospital, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University People's Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Peking University People's Hospital, Beijing 100044, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuguang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University People's Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University International Hospital, Beijing 102206, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University People's Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Peking University People's Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanguo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"R1-20250603","first-page":"504","article-title":"Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis","volume":"28","author":"Piga","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers","volume":"10","author":"Jeltsch-David","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00415-011-6232-5","article-title":"Systemic lupus erythematosus, the brain, and anti-NR2 antibodies","volume":"259","author":"Lauvsnes","year":"2012","journal-title":"J Neurol"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S1355617711000191","article-title":"Cognitive dysfunction and white matter abnormalities in systemic lupus erythematosus","volume":"17","author":"Kozora","year":"2011","journal-title":"J Int Neuropsychol Soc"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X","article-title":"Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation","volume":"45","author":"Ainiala","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.58.8.1214","article-title":"Neuropsychiatric syndromes in lupus: prevalence using standardized definitions","volume":"58","author":"Brey","year":"2002","journal-title":"Neurology"},{"key":"R7-20250603","first-page":"2156","article-title":"Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance","volume":"31","author":"Hanly","year":"2004","journal-title":"J Rheumatol"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/0961203313512540","article-title":"Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE)","volume":"23","author":"Zirkzee","year":"2014","journal-title":"Lupus"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0961203307078971","article-title":"Neuropsychiatric involvement in pediatric systemic lupus erythematosus","volume":"16","author":"Benseler","year":"2007","journal-title":"Lupus"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/03009740510026643","article-title":"Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study","volume":"34","author":"Ainiala","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.30157","article-title":"Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging","volume":"63","author":"Luyendijk","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.21483","article-title":"Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients","volume":"64","author":"Appenzeller","year":"2008","journal-title":"Ann Neurol"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/jnnp.68.2.170","article-title":"Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study","volume":"68","author":"Rovaris","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/WNN.0b013e318190d174","article-title":"White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus","volume":"22","author":"Filley","year":"2009","journal-title":"Cognit Behav Neurol"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/rheumatology\/41.6.619","article-title":"The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation","volume":"41","author":"Jennekens","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12016-007-8060-z","article-title":"Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus","volume":"34","author":"Appenzeller","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"R17-20250603","first-page":"915","article-title":"The morphologic correlate of incidental punctate white matter hyperintensities on MR images","volume":"12","author":"Fazekas","year":"1991","journal-title":"AJNR Am J Neuroradiol"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.43.9.1683","article-title":"Pathologic correlates of incidental MRI white matter signal hyperintensities","volume":"43","author":"Fazekas","year":"1993","journal-title":"Neurology"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00612126","article-title":"MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas","volume":"36","author":"Scarpelli","year":"1994","journal-title":"Neuroradiology"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0961203317707062","article-title":"Factors associated with increased white matter hyperintense lesion (WMHI) load in patients with systemic lupus erythematosus (SLE)","volume":"27","author":"Shaharir","year":"2018","journal-title":"Lupus"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1177\/0961203318763533","article-title":"White matter lesions and brain atrophy in systemic lupus erythematosus patients: Correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus","volume":"27","author":"Cannerfelt","year":"2018","journal-title":"Lupus"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0961203318816819","article-title":"Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort","volume":"28","author":"Magro-Checa","year":"2019","journal-title":"Lupus"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R25-20250603","first-page":"630","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients","volume":"35","author":"Bombardier","year":"1992","journal-title":"The Committee on Prognosis Studies in SLE Arthritis Rheum"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R27-20250603","first-page":"1983","article-title":"Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus","volume":"30","author":"Sibbitt","year":"2003","journal-title":"J Rheumatol"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.berh.2013.07.010","article-title":"Demyelinating disease in SLE: Is it multiple sclerosis or lupus?","volume":"27","author":"Checa","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/qjmed\/93.3.169","article-title":"Risk factors for central nervous system involvement in systemic lupus erythematosus","volume":"93","author":"Karassa","year":"2000","journal-title":"QJM"},{"key":"R30-20250603","first-page":"766","article-title":"Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus","volume":"28","author":"Mok","year":"2001","journal-title":"J Rheumatol"},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(199801)41:1<41::AID-ART6>3.0.CO;2-7","article-title":"Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease","volume":"41","author":"Kozora","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4081\/reumatismo.2017.1007","article-title":"Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series","volume":"69","author":"Chessa","year":"2017","journal-title":"Reumatismo"},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.numecd.2010.06.005","article-title":"Relationship between serum uric acid and cerebral white matter lesions in the elderly","volume":"22","author":"Shih","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R34-20250603","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1242\/jeb.01022","article-title":"Oxidants, antioxidants and the ischemic brain","volume":"207","author":"Warner","year":"2004","journal-title":"J Exp Biol"},{"key":"R35-20250603","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3389\/fimmu.2018.00983","article-title":"Monosodium urate crystals activate the inflamma-some in primary progressive multiple sclerosis","volume":"9","author":"Piancone","year":"2018","journal-title":"Front Immunol"},{"key":"R36-20250603","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jare.2017.10.011","article-title":"Silent cerebral MRI findings in lupus nephritis patients: is it clinically significant?","volume":"9","author":"Hussein","year":"2018","journal-title":"J Adv Res"},{"key":"R37-20250603","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.HYP.0000168052.00426.65","article-title":"Relationship between aortic stiffening and microvascular disease in brain and kidney: Cause and logic of therapy","volume":"46","author":"O\u2019Rourke","year":"2005","journal-title":"Hypertension"},{"key":"R38-20250603","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12471-015-0693-6","article-title":"Morphological and functional carotid vessel wall properties in relation to cerebral white matter lesions in myocardial infarction patients","volume":"23","author":"Kroner","year":"2015","journal-title":"Neth Heart J"},{"key":"R39-20250603","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.20745","article-title":"Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus","volume":"52","author":"Blanco","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R40-20250603","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/ard.2010.140012","article-title":"Expansion of myelin autoreactive CD8+ T lymphocytes in patients with neuropsychiatric systemic lupus erythematosus","volume":"70","author":"Contin-Bordes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R41-20250603","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/WCO.0b013e328352ea8b","article-title":"CD8-mediated inflammatory central nervous system disorders","volume":"25","author":"Willing","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"R42-20250603","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00281-010-0199-7","article-title":"Exploring the roles of CD8(+) T lymphocytes in the pathogenesis of autoimmune demyelination","volume":"32","author":"Johnson","year":"2010","journal-title":"Semin Immunopathol"},{"key":"R43-20250603","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/cns.13084","article-title":"IL-2mAb reduces demyelination after focal cerebral ischemia by suppressing CD8(+) T cells","volume":"25","author":"Zhou","year":"2019","journal-title":"CNS Neurosci Ther"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:01:41Z","timestamp":1748977301000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002074","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]}}}